Details of the Drug

General Information of Drug (ID: DM0J1R2)

Drug Name

VAC85135

Indication

Disease Entry	ICD 11	Status	REF
Myeloproliferative neoplasm	2A20	Phase 1	[1]
------------------------------------------------------------------------------------

Drug Type

Vaccine

Cross-matching ID

References

1	ClinicalTrials.gov (NCT05444530) A Phase 1 Study of VAC85135, a Neoantigen Vaccine Regimen, Concurrently Administered With Ipilimumab for the Treatment of Myeloproliferative Neoplasms. U.S.National Institutes of Health.